Literature DB >> 22832233

Control of the immune system by oxysterols and cancer development.

Catia Traversari1, Vincenzo Russo.   

Abstract

Oxysterols/oxysterol receptors have been shown to modulate several immune cell subsets, such as macrophages, T-cells and B-cells, neutrophils and dendritic cells (DCs). They participate in the control of several pathologic processes, that is, infectious diseases, atherosclerosis and autoimmunity. Moreover, some oxysterols have also been shown to favor tumor progression by dampening the antitumor immune response. The cellular responses generated by oxysterols depend on the engagement of Liver X Receptor (LXR) α and/or β isoforms, which induce activation of target genes or trans-repression of pro-inflammatory gene transcription. Recently, some reports have described a different mechanism of action of oxysterols, mediated by the engagement of G-Protein Coupled Receptors. Here, we summarize LXR-dependent and LXR-independent responses of oxysterols on immune cells with possible effects on tumor development.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832233     DOI: 10.1016/j.coph.2012.07.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  10 in total

Review 1.  Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses.

Authors:  Annette Graham; Anne-Marie Allen
Journal:  World J Cardiol       Date:  2015-05-26

Review 2.  Effects of Oxysterols on Immune Cells and Related Diseases.

Authors:  Fábio Alessandro de Freitas; Débora Levy; Cadiele Oliana Reichert; Edecio Cunha-Neto; Jorge Kalil; Sérgio Paulo Bydlowski
Journal:  Cells       Date:  2022-04-07       Impact factor: 7.666

3.  An altered peripheral IL6 response in major depressive disorder.

Authors:  Kelli M Money; Zita Olah; Zeljka Korade; Krassimira A Garbett; Richard C Shelton; Karoly Mirnics
Journal:  Neurobiol Dis       Date:  2016-01-22       Impact factor: 5.996

4.  On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment.

Authors:  Gerald Eibinger; Günter Fauler; Eva Bernhart; Sasa Frank; Astrid Hammer; Andrea Wintersperger; Hans Eder; Akos Heinemann; Paul S Mischel; Ernst Malle; Wolfgang Sattler
Journal:  Exp Cell Res       Date:  2013-03-26       Impact factor: 3.905

5.  Induction of pyroptosis in colon cancer cells by LXRβ.

Authors:  Cédric Rébé; Valentin Derangère; François Ghiringhelli
Journal:  Mol Cell Oncol       Date:  2015-02-24

6.  Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells.

Authors:  Mingyan He; Wenhui Zhang; Yinying Dong; Lishun Wang; Tingting Fang; Wenqing Tang; Bei Lv; Guanglang Chen; Biwei Yang; Peixin Huang; Jinglin Xia
Journal:  J Exp Clin Cancer Res       Date:  2017-01-18

7.  Hepatic Cholesterol-25-Hydroxylase Overexpression Improves Systemic Insulin Sensitivity in Mice.

Authors:  Britta Noebauer; Alexander Jais; Jelena Todoric; Klaus Gossens; Hedwig Sutterlüty-Fall; Elisa Einwallner
Journal:  J Diabetes Res       Date:  2017-02-19       Impact factor: 4.011

Review 8.  Multifaceted Functions of CH25H and 25HC to Modulate the Lipid Metabolism, Immune Responses, and Broadly Antiviral Activities.

Authors:  Jin Zhao; Jiaoshan Chen; Minchao Li; Musha Chen; Caijun Sun
Journal:  Viruses       Date:  2020-07-06       Impact factor: 5.048

9.  PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages.

Authors:  Lu Wang; Shuangshuang Li; Huanhua Luo; Qi Lu; Shuwen Yu
Journal:  J Exp Clin Cancer Res       Date:  2022-10-14

10.  High Cholesterol Diet-Induced Changes in Oxysterol and Scavenger Receptor Levels in Heart Tissue.

Authors:  Erdi Sozen; Burak Yazgan; Ali Sahin; Umit Ince; Nesrin Kartal Ozer
Journal:  Oxid Med Cell Longev       Date:  2018-06-13       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.